Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04540367 · ClinicalTrials.gov registry record · NA
Blood Flow Restriction Training for The Shoulder
A NA study, sponsored by The Methodist Hospital Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 69
- Enrollment target
NCT04540367 is a NA study that has completed, run by The Methodist Hospital Research Institute. The registered enrollment target is 69 participants.
The verdict
NCT04540367, a NA study, has completed, sponsored by The Methodist Hospital Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 69 participants
- Enrollment target
Study Summary
The aim of this study is to determine if BFR-LIX promotes greater increases in shoulder lean mass, rotator cuff strength, endurance, and acute increases in shoulder muscle activation compared to LIX alone.
Interventions
- DEVICE Blood flow restriction therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2017-11-10 |
| Est. Completion | 2020-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04540367
The ClinicalTrials.gov registry entry for NCT04540367 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Methodist Hospital Research Institute, which has 126 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood flow restriction therapy is the first listed.
NCT04540367 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04540367 about?
NCT04540367 is a clinical study titled "Blood Flow Restriction Training for The Shoulder". The aim of this study is to determine if BFR-LIX promotes greater increases in shoulder lean mass, rotator cuff strength, endurance, and acute increases in shoulder muscle activation compared to LIX alone.
What is the current status of trial NCT04540367?
This trial is currently completed. It is a NA study. The enrollment target is 69 participants. The study started on 2017-11-10. Estimated completion is 2020-08-01.
What interventions are being tested in trial NCT04540367?
The interventions under investigation include: Blood flow restriction therapy (DEVICE).
Who is sponsoring clinical trial NCT04540367?
This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.